DEL-22379 was previously shown to trigger apoptosis in melanoma- and CRC-derived cell lines depending on their mutational status, and the cytotoxic effects were more pronounced in BRAF-mutant cells, variable in RAS-mutant cells and negligible in cells wild-type for both oncogenes [18]. The gene discussed is BRAF; the disease is melanoma.